Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,485 | -2,344 | -1,542 | -169 |
| Depreciation Amortization | 1 | 0 | N/A | N/A |
| Other Working Capital | -89 | 310 | 165 | 54 |
| Other Operating Activity | 4,051 | 1,541 | 1,140 | 8 |
| Operating Cash Flow | $-522 | $-493 | $-238 | $-107 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -75 | 0 | N/A | N/A |
| Investing Cash Flow | $-75 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | N/A | 1,190 | 1,190 |
| Other Financing Activity | -132 | 1,117 | -61 | 0 |
| Financing Cash Flow | $-132 | $1,117 | $1,129 | $1,190 |
| Beginning Cash Position | 828 | 204 | 205 | 205 |
| End Cash Position | 99 | 828 | 1,096 | 1,288 |
| Net Cash Flow | $-729 | $624 | $892 | $1,083 |
| Free Cash Flow | ||||
| Operating Cash Flow | -522 | -493 | -238 | -107 |
| Capital Expenditure | -75 | N/A | N/A | N/A |
| Free Cash Flow | -598 | -493 | -238 | -107 |